Experienced in Pseudobulbar Affect

Dr. Thomas C. Klein

Family Medicine
1709 S Rock Rd, 
Wichita, KS 
Experienced in Pseudobulbar Affect
1709 S Rock Rd, 
Wichita, KS 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Thomas Klein is a primary care provider, practicing in Family Medicine in Wichita, Kansas. Dr. Klein is rated as an Experienced provider by MediFind in the treatment of Pseudobulbar Affect. His top areas of expertise are Factor 12 Deficiency, High Molecular Weight Kininogen Deficiency, Congenital Afibrinogenemia, and Factor 5 Deficiency.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Family Medicine
Licenses
Family Medicine in KS
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

1709 S Rock Rd, Wichita, KS 67207

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Enrollment Status: Completed
Publish Date: January 24, 2025
Intervention Type: Drug
Study Drug: Tirzepatide
Study Phase: Phase 2
A Phase III, Randomized, Controlled, Observer-blind Study to Demonstrate Effectiveness, Immunogenicity and Safety of GSK's Meningococcal Group B and Combined ABCWY Vaccines When Administered to Healthy Adolescents and Young Adults
A Phase III, Randomized, Controlled, Observer-blind Study to Demonstrate Effectiveness, Immunogenicity and Safety of GSK's Meningococcal Group B and Combined ABCWY Vaccines When Administered to Healthy Adolescents and Young Adults
Enrollment Status: Completed
Publish Date: March 05, 2024
Intervention Type: Combination product, Biological
Study Phase: Phase 3
A Phase 2 Randomized, Double-blind, Placebo-controlled Study in HLA-DQ2.5+ Adults With Celiac Disease to Assess the Effect of Nexvax2 on Symptoms After Masked Gluten Food Challenge
A Phase 2 Randomized, Double-blind, Placebo-controlled Study in HLA-DQ2.5+ Adults With Celiac Disease to Assess the Effect of Nexvax2 on Symptoms After Masked Gluten Food Challenge
Enrollment Status: Unknown
Publish Date: March 19, 2019
Intervention Type: Biological
Study Drug: Nexvax2
Study Phase: Phase 2
View 2 Less Clinical Trials

1 Total Publications

Breadth of coverage against a panel of 110 invasive disease isolates, immunogenicity and safety for 2 and 3 doses of an investigational MenABCWY vaccine in US adolescents - Results from a randomized, controlled, observer-blind phase II study.
Breadth of coverage against a panel of 110 invasive disease isolates, immunogenicity and safety for 2 and 3 doses of an investigational MenABCWY vaccine in US adolescents - Results from a randomized, controlled, observer-blind phase II study.
Journal: Vaccine
Published: March 02, 2018
Similar Doctors
Experienced in Pseudobulbar Affect
Dr. Rodney K. Bryant
Geriatrics | Family Medicine | Internal Medicine
Experienced in Pseudobulbar Affect
Dr. Rodney K. Bryant
Geriatrics | Family Medicine | Internal Medicine

Nv Pacs 2 LLC

501 Easy St, 
Goddard, KS 
 (18.5 miles away)
316-794-8635
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Rodney Bryant is a primary care provider, practicing in Geriatrics and Internal Medicine in Goddard, Kansas. Dr. Bryant is rated as an Advanced provider by MediFind in the treatment of Pseudobulbar Affect. His top areas of expertise are Anemia, Dementia, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young. Dr. Bryant is currently accepting new patients.

Experienced in Pseudobulbar Affect
Dr. Geri H. Hart
Family Medicine
Experienced in Pseudobulbar Affect
Dr. Geri H. Hart
Family Medicine

Hutchinson Clinic P A Inc

2101 N Waldron St, 
Hutchinson, KS 
 (45.7 miles away)
620-669-2500
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Geri Hart is a primary care provider, practicing in Family Medicine in Hutchinson, Kansas. Dr. Hart is rated as a Distinguished provider by MediFind in the treatment of Pseudobulbar Affect. Her top areas of expertise are Hypertension, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, and Anemia. Dr. Hart is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Klein's expertise for a condition
ConditionClose
      View All 9 Advanced Conditions
      View All 43 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile